Skip to content
Blog

Blog

Tech news, AI analysis, tutorials, and opinion pieces.

165 articles available

OpenAI Brings Codex to the ChatGPT Mobile App: Your Phone Is Now a Control Surface (May 2026)
analysis

OpenAI Brings Codex to the ChatGPT Mobile App: Your Phone Is Now a Control Surface (May 2026)

OpenAI announced on May 14, 2026 that Codex is coming to the ChatGPT mobile app on iOS and Android, rolling out May 15 as a preview across all plans including Free and Go. The phone becomes a control surface, not an execution device: you supervise, approve, redirect, and reassign Codex sessions running on your laptop, Mac mini, or devbox. OpenAI says Codex has more than 4 million weekly users, and the strategic story is the bid to own the async supervision surface as cloud handoff becomes the category default.

16 min read
Read
arXiv Will Ban You for a Year If You Let an LLM Do the Whole Paper
analysis

arXiv Will Ban You for a Year If You Let an LLM Do the Whole Paper

arXiv will ban authors for one year if there is incontrovertible evidence they did not verify their LLM output. It bans negligence, not AI — and shifts liability to the author.

14 min read
Read
Greg Brockman Takes Over OpenAI Product Strategy: The Pre-IPO Org Reshuffle Decoded (May 2026)
analysis

Greg Brockman Takes Over OpenAI Product Strategy: The Pre-IPO Org Reshuffle Decoded (May 2026)

Greg Brockman reportedly takes permanent charge of OpenAI product strategy on May 16, 2026, merging ChatGPT, Codex, and the API into one team. We decode the pre-IPO org-design signal against the Musk v. Altman governance backdrop.

17 min read
Read
The First AI Encyclical: Pope Leo XIV, Anthropic, and the Magnifica Humanitas Strategic Read
analysis

The First AI Encyclical: Pope Leo XIV, Anthropic, and the Magnifica Humanitas Strategic Read

Pope Leo XIV publishes Magnifica Humanitas, the first papal encyclical on AI, on May 25, 2026, with Anthropic co-founder Christopher Olah on the Vatican launch panel. A neutral strategic analysis of the faith-tech intersection, Anthropic positioning, and the global AI safety discourse.

13 min read
Read
1X NEO — First Consumer Humanoid With a Price and a Date (and a Catch)
analysis

1X NEO — First Consumer Humanoid With a Price and a Date (and a Catch)

NEO is 1X Technologies' 1.65 m household humanoid, confirmed for US delivery by end of 2026 at ~$20,000 or ~$500 per month. First consumer humanoid with a date and a price — with a remote teleoperation caveat.

13 min read
Read
FDA Launches Real-Time AI Clinical Trial Pilot: Inside the 20-40% Drug-Approval Time Bet
analysis

FDA Launches Real-Time AI Clinical Trial Pilot: Inside the 20-40% Drug-Approval Time Bet

The FDA launched its first real-time AI-driven clinical trial pilot in May 2026. Chief AI Officer Jeremy Walsh estimates 20 to 40 percent trial-time reduction via continuous cloud monitoring. RFI closed May 29; expansion decision expected summer 2026.

13 min read
Read
Cohere Command A: 111B Open-Weights, 256K Context, Runs on 2 GPUs
analysis

Cohere Command A: 111B Open-Weights, 256K Context, Runs on 2 GPUs

Cohere Command A is a 111B open-weights enterprise model with a 256K context window, 23-language support, and a two-GPU serving footprint that makes private deployment realistic. Cohere claims parity with GPT-4o and DeepSeek-V3 on agentic enterprise tasks. We analyze why the lab everyone forgets is one of the best-positioned vendors for the regulated, multilingual enterprise.

15 min read
Read
Udio Acknowledges YouTube Training Data in Sony Music v. Udio: The Fair Use Defense and the Provenance War (May 2026)
analysis

Udio Acknowledges YouTube Training Data in Sony Music v. Udio: The Fair Use Defense and the Provenance War (May 2026)

According to Music Ally and Digital Music News reporting on May 6, 2026, a court filing in Sony Music v. Udio indicated that AI music generator Udio obtained some of its training audio from YouTube, and Udio is defending the practice under a fair use theory. The disclosure lands during active copyright litigation against Udio and Suno brought by Universal Music Group and Sony Music. None of the allegations has been adjudicated and the fair use question is unresolved. The strategic story: data provenance, not just output similarity, has become the central front in the AI music copyright war, with the market splitting into a litigated tier (Suno, Udio) and a licensed-clean tier (ElevenLabs).

14 min read
Read
Robotera Raised $200M+ and Started Shipping Humanoids by the Thousand — China Just Industrialized the Robot
analysis

Robotera Raised $200M+ and Started Shipping Humanoids by the Thousand — China Just Industrialized the Robot

Robotera raised more than $200M led by SF Group and began thousand-unit humanoid deliveries in Q2 2026 with 300%+ growth. The underreported signal: China leads humanoid volume, not just capability.

17 min read
Read
Prime Intellect Lab Goes GA: The DIY Frontier AI Lab for Decentralized Self-Improving Agent Training (May 7, 2026)
analysis

Prime Intellect Lab Goes GA: The DIY Frontier AI Lab for Decentralized Self-Improving Agent Training (May 7, 2026)

Prime Intellect Lab exited beta on May 7, 2026 — a full-stack decentralized platform for training self-improving agents, with 10,000+ beta jobs, per-token pricing, 14 base models, and backers including Karpathy, Delangue, Tri Dao, and Mostaque.

16 min read
Read
Hollywood’s First Big AI Deal Stalled — Lionsgate-Runway, and Where Studios Pivoted (May 2026)
analysis

Hollywood’s First Big AI Deal Stalled — Lionsgate-Runway, and Where Studios Pivoted (May 2026)

Hollywood’s first major studio-AI deal, Lionsgate-Runway (announced September 18, 2024), did not deliver its promised custom film model. Per a TheWrap exclusive by Roger Cheng and Jeremy Fuster, a single studio catalog — even Disney’s — is reportedly too small to train a production-grade video model. Lionsgate says the deal is not exclusive and continues on several fronts. Meanwhile OpenAI’s roughly $30M Critterz heads to the Cannes market and Amazon’s Alexa Fund backs Fable Studio’s Showrunner. A scoped contrarian read on the studio-production wall.

15 min read
Read
ApexGO: A Penn AI Designs Antibiotics That Beat a Last-Resort Drug
analysis

ApexGO: A Penn AI Designs Antibiotics That Beat a Last-Resort Drug

Penn's ApexGO AI designed antimicrobial peptides that matched polymyxin B, a last-resort antibiotic, in mice. 85% halted bacterial growth, 72% beat the original. Nature Machine Intelligence.

16 min read
Read